Cargando…
Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415894/ https://www.ncbi.nlm.nih.gov/pubmed/34487683 http://dx.doi.org/10.1016/S2352-3026(21)00274-X |
| _version_ | 1783748059293810688 |
|---|---|
| author | Redjoul, Rabah Le Bouter, Anne Parinet, Vincent Fourati, Slim Maury, Sébastien |
| author_facet | Redjoul, Rabah Le Bouter, Anne Parinet, Vincent Fourati, Slim Maury, Sébastien |
| author_sort | Redjoul, Rabah |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8415894 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84158942021-09-07 Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT Redjoul, Rabah Le Bouter, Anne Parinet, Vincent Fourati, Slim Maury, Sébastien Lancet Haematol Comment Elsevier Ltd. 2021-10 2021-09-03 /pmc/articles/PMC8415894/ /pubmed/34487683 http://dx.doi.org/10.1016/S2352-3026(21)00274-X Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Redjoul, Rabah Le Bouter, Anne Parinet, Vincent Fourati, Slim Maury, Sébastien Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT |
| title | Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT |
| title_full | Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT |
| title_fullStr | Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT |
| title_full_unstemmed | Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT |
| title_short | Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT |
| title_sort | antibody response after third bnt162b2 dose in recipients of allogeneic hsct |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415894/ https://www.ncbi.nlm.nih.gov/pubmed/34487683 http://dx.doi.org/10.1016/S2352-3026(21)00274-X |
| work_keys_str_mv | AT redjoulrabah antibodyresponseafterthirdbnt162b2doseinrecipientsofallogeneichsct AT lebouteranne antibodyresponseafterthirdbnt162b2doseinrecipientsofallogeneichsct AT parinetvincent antibodyresponseafterthirdbnt162b2doseinrecipientsofallogeneichsct AT fouratislim antibodyresponseafterthirdbnt162b2doseinrecipientsofallogeneichsct AT maurysebastien antibodyresponseafterthirdbnt162b2doseinrecipientsofallogeneichsct |